These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28830840)

  • 1. Binge-eating disorder: Clinical and therapeutic advances.
    Hutson PH; Balodis IM; Potenza MN
    Pharmacol Ther; 2018 Feb; 182():15-27. PubMed ID: 28830840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics.
    Boswell RG; Potenza MN; Grilo CM
    Clin Ther; 2021 Jan; 43(1):50-69. PubMed ID: 33257092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational drugs for the treatment of binge eating disorder (BED): an update.
    Appolinario JC; Nardi AE; McElroy SL
    Expert Opin Investig Drugs; 2019 Dec; 28(12):1081-1094. PubMed ID: 31714807
    [No Abstract]   [Full Text] [Related]  

  • 4. The neurobiological basis of binge-eating disorder.
    Kessler RM; Hutson PH; Herman BK; Potenza MN
    Neurosci Biobehav Rev; 2016 Apr; 63():223-38. PubMed ID: 26850211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsivity and compulsivity in binge eating disorder: A systematic review of behavioral studies.
    Carr MM; Wiedemann AA; Macdonald-Gagnon G; Potenza MN
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110318. PubMed ID: 33794320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.
    Grilo CM; Reas DL; Mitchell JE
    Curr Psychiatry Rep; 2016 Jun; 18(6):55. PubMed ID: 27086316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and emerging drug treatments for binge eating disorder.
    Reas DL; Grilo CM
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):99-142. PubMed ID: 24460483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological approaches to the management of binge eating disorder.
    Brownley KA; Peat CM; La Via M; Bulik CM
    Drugs; 2015 Jan; 75(1):9-32. PubMed ID: 25428709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binge eating in pre-clinical models.
    Rospond B; Szpigiel J; Sadakierska-Chudy A; Filip M
    Pharmacol Rep; 2015 Jun; 67(3):504-12. PubMed ID: 25933962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive biases in binge eating disorder: the hijacking of decision making.
    Voon V
    CNS Spectr; 2015 Dec; 20(6):566-73. PubMed ID: 26594850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behind binge eating: A review of food-specific adaptations of neurocognitive and neuroimaging tasks.
    Berner LA; Winter SR; Matheson BE; Benson L; Lowe MR
    Physiol Behav; 2017 Jul; 176():59-70. PubMed ID: 28363840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
    Heal DJ; Smith SL
    J Psychopharmacol; 2022 Jun; 36(6):680-703. PubMed ID: 34318734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic Treatments for Binge-Eating Disorder.
    McElroy SL
    J Clin Psychiatry; 2017; 78 Suppl 1():14-19. PubMed ID: 28125174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food-related impulsivity in obesity and binge eating disorder--a systematic review.
    Schag K; Schönleber J; Teufel M; Zipfel S; Giel KE
    Obes Rev; 2013 Jun; 14(6):477-95. PubMed ID: 23331770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interventions for binge eating: lessons from animal models, current treatments, and future directions.
    Berner LA; Bocarsly ME; Hoebel BG; Avena NM
    Curr Pharm Des; 2011; 17(12):1180-7. PubMed ID: 21492094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Would glucagon-like peptide-1 receptor agonists have efficacy in binge eating disorder and bulimia nervosa? A review of the current literature.
    McElroy SL; Mori N; Guerdjikova AI; Keck PE
    Med Hypotheses; 2018 Feb; 111():90-93. PubMed ID: 29407005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in neuroimaging to model eating disorder neurobiology.
    Frank GK
    Curr Psychiatry Rep; 2015 Apr; 17(4):559. PubMed ID: 25749747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different moderators of cognitive-behavioral therapy on subjective and objective binge eating in bulimia nervosa and binge eating disorder: a three-year follow-up study.
    Castellini G; Mannucci E; Lo Sauro C; Benni L; Lazzeretti L; Ravaldi C; Rotella CM; Faravelli C; Ricca V
    Psychother Psychosom; 2012; 81(1):11-20. PubMed ID: 22116257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin.
    Steward T
    Trends Mol Med; 2024 Apr; 30(4):321-323. PubMed ID: 38123380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.